Determination of micronuclei frequency in Danio rerio for assessing genotoxicity induced by propineb.

Autor: Rasgele PG; Department of Biosystems Engineering, Faculty of Agriculture, Duzce University, Duzce, Türkiye., Demir F; Department of Biology, Graduate School, Duzce University, Duzce, Türkiye., Kirankaya SG; Department of Biology, Faculty of Art and Sciences, Duzce University, Duzce, Türkiye.

Publikováno v: Drug and chemical toxicology [Drug Chem Toxicol] 2024 Nov; Vol. 47 (6), pp. 848-853. Date of Electronic Publication: 2024 Jan 15.

Objectives and achievements of the HUMN project on its 26th anniversary.

Autor: Fenech M; Health and Biomedical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide 5000, Australia; Genome Health Foundation, North Brighton, SA 5048, Australia. Electronic address: Michael.Fenech@unisa.edu.au., Holland N; Center for Environmental Research and Community Health (CERCH), University of California, Berkeley, Berkeley, CA, USA. Electronic address: ninah@berkeley.edu., Zeiger E; Errol Zeiger Consulting, Chapel Hill, NC, USA. Electronic address: zeiger@nc.rr.com., Chang PW; Show Chwan Memorial Hospital, Changhwa, Taiwan; TUFTS University Medical School, Boston, USA. Electronic address: peter.chang3@gmail.com., Kirsch-Volders M; Laboratory for Cell Genetics, Department Biology, Faculty of Sciences and Bio-engineering Sciences, Vrije Universiteit Brussel, Pleinlaan 2, Brussels 1050, Belgium. Electronic address: mkirschv@vub.be., Bolognesi C; Environmental Carcinogenesis Unit, Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: claudiabolognesi@yahoo.it., Stopper H; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg 97080, Germany. Electronic address: helga.stopper@uni-wuerzburg.de., Knudsen LE; Department of Public Health, Section of Environmental Health, University of Copenhagen, Copenhagen, Denmark. Electronic address: liek@sund.ku.dk., Knasmueller S; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Electronic address: siegfried.knasmueller@meduniwien.ac.at., Nersesyan A; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Electronic address: anersesyan@yahoo.com., Thomas P; CSIRO Health and Biosecurity, Adelaide 5000, Australia. Electronic address: phil.t63@hotmail.com., Dhillon V; Health and Biomedical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide 5000, Australia. Electronic address: Varinderpal.Dhillon@unisa.edu.au., Deo P; Health and Biomedical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide 5000, Australia. Electronic address: Permal.Deo@unisa.edu.au., Franzke B; Department of Nutritional Sciences, University of Vienna, Austria. Electronic address: bernhard.franzke@univie.ac.at., Andreassi MG; CNR Institute of Clinical Physiology, Pisa 56124, Italy. Electronic address: andreas@ifc.cnr.it., Laffon B; Universidade da Coruña, Grupo DICOMOSA, CICA-Centro Interdisciplinar de Química e Bioloxía, Departamento de Psicología, Facultad de Ciencias de la Educación, and Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, A Coruña, Spain. Electronic address: blanca.laffon@udc.es., Wagner KH; Department of Nutritional Sciences, University of Vienna, Austria; Research Platform Active Ageing, University of Vienna, Austria. Electronic address: karl-heinz.wagner@univie.ac.at., Norppa H; Finnish Institute of Occupational Health, Helsinki 00250, Finland. Electronic address: hannu.norppa@outlook.com., da Silva J; Laboratory of Genetic Toxicology, La Salle University (UniLaSalle), Canoas, RS 92010-000, Brazil; PPGBM, Federal University of Brazil (UFRGS), Porto Alegre 91501-970, Brazil. Electronic address: juliana.silva@unilasalle.edu.br., Volpi EV; School of Life Sciences, University of Westminster, 115 New Cavendish Street, London W1W6UW, UK. Electronic address: e.volpi@westminster.ac.uk., Wilkins R; Environmental and Radiation Health Sciences Directorate, Health Canada 775 Brookfield Rd, Ottawa K1A 1C1, Canada. Electronic address: ruth.wilkins@hc-sc.gc.ca., Bonassi S; Clinical and Molecular Epidemiology, IRCCS San Raffaele Roma, Rome 00166, Italy. Electronic address: stefano.bonassi@sanraffaele.it.

Publikováno v: Mutation research. Reviews in mutation research [Mutat Res Rev Mutat Res] 2024 Jul-Dec; Vol. 794, pp. 108511. Date of Electronic Publication: 2024 Sep 02.

Micronuclear collapse from oxidative damage.

Autor: Di Bona M; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Chen Y; Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Agustinus AS; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Pharmacology Graduate Program, Weill Cornell Medicine, New York, NY 10065, USA., Mazzagatti A; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Duran MA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Deyell M; Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY 10065, USA., Bronder D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Hickling J; Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Hong C; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Scipioni L; School of Engineering, University of California, Irvine, CA 92697, USA.; Laboratory for Fluorescence Dynamics, University of California, Irvine, Irvine, CA 92617, USA., Tedeschi G; School of Engineering, University of California, Irvine, CA 92697, USA.; Laboratory for Fluorescence Dynamics, University of California, Irvine, Irvine, CA 92617, USA., Martin S; Department of Experimental Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy., Li J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Ruzgaitė A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Riaz N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Shah P; Systems Biology Department, Columbia University, New York, NY 10032, USA., D'Souza EK; Systems Biology Department, Columbia University, New York, NY 10032, USA., Brodtman DZ; Systems Biology Department, Columbia University, New York, NY 10032, USA., Sidoli S; Department of Biochemistry, Albert Einstein College of Medicine, New York, NY 10461, USA., Diplas B; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Jalan M; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Lee NY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Ordureau A; Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Izar B; Systems Biology Department, Columbia University, New York, NY 10032, USA., Laughney AM; Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY 10065, USA., Powell S; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Gratton E; School of Engineering, University of California, Irvine, CA 92697, USA., Santaguida S; Department of Experimental Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Maciejowski J; Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Ly P; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Jeitner TM; Department of Radiology, Weill Cornell Medicine, New York, NY 10065, USA., Bakhoum SF; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Publikováno v: Science (New York, N.Y.) [Science] 2024 Aug 30; Vol. 385 (6712), pp. eadj8691. Date of Electronic Publication: 2024 Aug 30.

Micronuclei and other nuclear anomalies in exfoliated urothelial cells and urinary 8-hydroxy-deoxyguanosine levels among Turkish hairdressers.

Autor: Sukuroglu AA; Mersin University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Mersin 33169, Turkey. Electronic address: aktasayca@mersin.edu.tr., Burgaz S; Gazi University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Ankara 06330, Turkey.

Publikováno v: Mutation research. Genetic toxicology and environmental mutagenesis [Mutat Res Genet Toxicol Environ Mutagen] 2024 May-Jun; Vol. 896, pp. 503754. Date of Electronic Publication: 2024 Mar 29.

Genetic determinants of micronucleus formation in vivo.

Autor: Adams DJ; Wellcome Sanger Institute, Cambridge, UK. da1@sanger.ac.uk., Barlas B; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., McIntyre RE; Wellcome Sanger Institute, Cambridge, UK., Salguero I; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK., van der Weyden L; Wellcome Sanger Institute, Cambridge, UK., Barros A; Wellcome Sanger Institute, Cambridge, UK.; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK., Vicente JR; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Karimpour N; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Haider A; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Ranzani M; Wellcome Sanger Institute, Cambridge, UK., Turner G; Wellcome Sanger Institute, Cambridge, UK., Thompson NA; Wellcome Sanger Institute, Cambridge, UK., Harle V; Wellcome Sanger Institute, Cambridge, UK., Olvera-León R; Wellcome Sanger Institute, Cambridge, UK., Robles-Espinoza CD; Wellcome Sanger Institute, Cambridge, UK.; Laboratorio Internacional de Investigación Sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro, México., Speak AO; Wellcome Sanger Institute, Cambridge, UK., Geisler N; Wellcome Sanger Institute, Cambridge, UK.; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK., Weninger WJ; Division of Anatomy, MIC, Medical University of Vienna, Wien, Austria., Geyer SH; Division of Anatomy, MIC, Medical University of Vienna, Wien, Austria., Hewinson J; Wellcome Sanger Institute, Cambridge, UK., Karp NA; Wellcome Sanger Institute, Cambridge, UK., Fu B; Wellcome Sanger Institute, Cambridge, UK., Yang F; Wellcome Sanger Institute, Cambridge, UK., Kozik Z; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London, UK., Choudhary J; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London, UK., Yu L; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London, UK., van Ruiten MS; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rowland BD; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lelliott CJ; Wellcome Sanger Institute, Cambridge, UK., Del Castillo Velasco-Herrera M; Wellcome Sanger Institute, Cambridge, UK., Verstraten R; Wellcome Sanger Institute, Cambridge, UK., Bruckner L; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany., Henssen AG; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.; Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Rooimans MA; Department of Human Genetics, Section of Oncogenetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands., de Lange J; Department of Human Genetics, Section of Oncogenetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands., Mohun TJ; Division of Developmental Biology, MRC, National Institute for Medical Research, London, UK., Arends MJ; Division of Pathology, Cancer Research UK Scotland Centre, Institute of Genetics & Cancer The University of Edinburgh, Edinburgh, UK., Kentistou KA; MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, UK., Coelho PA; Department of Genetics, University of Cambridge, Cambridge, UK., Zhao Y; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Zecchini H; Metabolic Research Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, UK., Perry JRB; MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, UK.; Metabolic Research Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, UK., Jackson SP; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Institute, Cambridge, UK., Balmus G; Wellcome Sanger Institute, Cambridge, UK. gb318@cam.ac.uk.; UK Dementia Research Institute at the University of Cambridge, University of Cambridge, Cambridge, UK. gb318@cam.ac.uk.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. gb318@cam.ac.uk.; The Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK. gb318@cam.ac.uk.; Department of Molecular Neuroscience, Transylvanian Institute of Neuroscience, Cluj-Napoca, Romania. gb318@cam.ac.uk.

Publikováno v: Nature [Nature] 2024 Mar; Vol. 627 (8002), pp. 130-136. Date of Electronic Publication: 2024 Feb 14.